Form 4: Immuneering Corp Director Peter Feinberg Increases Stake with $25,000 Purchase

Director Peter Feinberg increased his holdings in Immuneering Corp (IMRX) by purchasing 25,000 shares of Class A Common Stock at an average price of $2.5485 on March 22, 2024.

Summary

• On March 22, 2024, Peter Feinberg, a director of Immuneering Corp (IMRX), purchased 25,000 shares of Class A Common Stock.
• The purchase was executed through a broker-dealer at prices ranging from $2.52 to $2.57, with a weighted average purchase price of $2.5485.
• Following the transaction, Feinberg directly owns 111,766 shares of Class A Common Stock.
• Feinberg also indirectly owns shares through his role as General Partner of PF Associates L.P. (392,242 shares), PEF LLC (476,615 shares), and S4K Investments LLC (115,441 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's just a single director's purchase, insider buying is generally viewed favorably. However, the amount is not substantial enough to significantly alter the overall outlook.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It can be a positive signal, especially when a director increases their holdings.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates